Aug 222012
 

Sickle Cell Conference We’re happy to announce that we’re attending, presenting and co-sponsoring the first annual Sickle Cell Disease Therapeutics Conference the third week of September, Wednesday 9/19.  This is a forum to discuss the latest advancements and future trends for treating patients with sickle cell disease. Brinson Patrick Managing Director and life sciences analyst Michael Higgins will be co-presenting The Patient Experience Q&A with sickle cell disease patient Andre Louissaint.  Learn more here, and see you there.

Mar 222012
 

Today we are announcing the initiation of research coverage of Akorn, Inc.(NASDAQ: AKRX), a company that develops, manufactures and markets multisource and branded pharmaceuticals. The report, issued by our analyst Michael Higgins, is the first one of the firm’s new equity research department, which was established in January.

Brinson Patrick Securities Initiates Research Coverage of Akorn, Inc.